These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 15539915

  • 1. Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial.
    Uhlmann C, Ballabeni P, Rijken N, Brauchli P, Mingrone W, Rauch D, Pestalozzi BC, Rochlitz C, Aebi S, Swiss Group for Clinical Cancer Research, Swiss Institute for Applied Cancer Research.
    Oncology; 2004; 67(2):117-22. PubMed ID: 15539915
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.
    Blum JL, Dees EC, Chacko A, Doane L, Ethirajan S, Hopkins J, McMahon R, Merten S, Negron A, Neubauer M, Ilegbodu D, Boehm KA, Asmar L, O'Shaughnessy JA.
    J Clin Oncol; 2006 Sep 20; 24(27):4384-90. PubMed ID: 16926223
    [Abstract] [Full Text] [Related]

  • 3. Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group.
    Masuda N, Taguchi T, Nakayama T, Shiba E, Watatani M, Kurebayashi J, Takatsuka Y, Sakamoto J, Noguchi S, Kinki Breast Cancer Study Group (KBCSG).
    Cancer Chemother Pharmacol; 2008 May 20; 61(6):989-95. PubMed ID: 17641893
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 20; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 5. Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer.
    Susnjar S, Bosnjak S, Radulovic S, Stevanovic J, Gajic-Dobrosavljevic M, Kreacic M.
    J BUON; 2007 Oct 20; 12(2):189-96. PubMed ID: 17600871
    [Abstract] [Full Text] [Related]

  • 6. A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer.
    Lortholary A, Hardy-Bessard AC, Bachelot T, de Rauglaudre G, Alexandre J, Bourgeois H, Jaubert D, Paraiso D, Largillier R.
    Breast Cancer Res Treat; 2012 Jan 20; 131(1):127-35. PubMed ID: 21947680
    [Abstract] [Full Text] [Related]

  • 7. Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.
    Blum JL, Dees EC, Vukelja SJ, Amare M, Gill DP, McMahon RT, Ilegbodu D, Asmar L, O'Shaughnessy JA.
    Clin Breast Cancer; 2007 Feb 20; 7(6):465-70. PubMed ID: 17386123
    [Abstract] [Full Text] [Related]

  • 8. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
    Rossi D, Alessandroni P, Catalano V, Giordani P, Fedeli SL, Fedeli A, Baldelli AM, Casadei V, Ceccolini M, Catalano G.
    Clin Breast Cancer; 2007 Dec 20; 7(11):857-60. PubMed ID: 18269775
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.
    Mrozek E, Ramaswamy B, Young D, Rhoades CA, Kendra K, Allen J, Moore T, Hauger M, Watson H, Merriman N, Nadella P, Villalona-Calero M, Shapiro CL.
    Clin Breast Cancer; 2006 Jun 20; 7(2):141-5. PubMed ID: 16800973
    [Abstract] [Full Text] [Related]

  • 10. Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancer.
    Schwartzberg LS, Arena FP, Mintzer DM, Epperson AL, Walker MS.
    Clin Breast Cancer; 2012 Apr 20; 12(2):87-93. PubMed ID: 22154117
    [Abstract] [Full Text] [Related]

  • 11. [A phase I study of combination therapy with capecitabine and paclitaxel for patients with inoperable breast cancer or recurrent breast cancer].
    Horiguchi J, Koibuchi Y, Rokutanda N, Nagaoka R, Kikuchi M, Sato A, Odawara H, Ishikawa Y, Tokiniwa H, Iino Y, Takeyoshi I.
    Gan To Kagaku Ryoho; 2008 Nov 20; 35(11):1877-81. PubMed ID: 19011335
    [Abstract] [Full Text] [Related]

  • 12. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D, Frassineti GL, Zoli W, Milandri C, Tienghi A, Ravaioli A, Gentile A, Salzano E.
    Semin Oncol; 1996 Oct 20; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [Abstract] [Full Text] [Related]

  • 13. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
    Klaassen U, Harstrick A, Wilke H, Seeber S.
    Semin Oncol; 1996 Feb 20; 23(1 Suppl 1):44-7. PubMed ID: 8629037
    [Abstract] [Full Text] [Related]

  • 14. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
    D'Andrea G, Fennelly D, Norton L, Baselga J, Gilewski T, Hudis C, Moynahan ME, Raptis G, Sklarin N, Surbone A, Theodoulou M, Templeton MA, Yao TJ, Seidman AD.
    Clin Cancer Res; 1999 Feb 20; 5(2):275-9. PubMed ID: 10037175
    [Abstract] [Full Text] [Related]

  • 15. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
    O'connor T, Rustum Y, Levine E, Creaven P.
    Cancer Chemother Pharmacol; 2008 Jan 20; 61(1):125-31. PubMed ID: 17426973
    [Abstract] [Full Text] [Related]

  • 16. Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL.
    Di Costanzo F, Gasperoni S, Papaldo P, Bilancia D, Manzione L, Landucci E, Mazzoni F, Cognetti F, Gruppo Oncologico Italiano di Ricerca clinica, Gruppo Oncologico del Lazio.
    Ann Oncol; 2006 Jan 20; 17(1):79-84. PubMed ID: 16284056
    [Abstract] [Full Text] [Related]

  • 17. Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results.
    Michalaki V, Gennatas S, Gennatas K.
    Anticancer Drugs; 2009 Mar 20; 20(3):204-7. PubMed ID: 19174694
    [Abstract] [Full Text] [Related]

  • 18. Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer.
    Favier L, Isambert N, Zanetta S, Ferrant E, Mayer F, Chauffert B, Fumoleau P, Garnier J, Biville F, Coudert B.
    Breast; 2008 Feb 20; 17(1):36-41. PubMed ID: 17698359
    [Abstract] [Full Text] [Related]

  • 19. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.
    Sym SJ, Ryu MH, Kang HJ, Lee SS, Chang HM, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK.
    Cancer Chemother Pharmacol; 2010 Jul 20; 66(2):373-80. PubMed ID: 19936751
    [Abstract] [Full Text] [Related]

  • 20. Final results of a phase II clinical trial of weekly docetaxel in combination with capecitabine in anthracycline-pretreated metastatic breast cancer.
    Mackey JR, Tonkin KS, Koski SL, Scarfe AG, Smylie MG, Joy AA, Au HJ, Bodnar DM, Soulieres D, Smith SW.
    Clin Breast Cancer; 2004 Oct 20; 5(4):287-92. PubMed ID: 15507175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.